NEW ORLEANS — Povorcitinib was associated with substantial repigmentation in patients with extensive nonsegmental vitiligo, according to a study presented at the American Academy of Dermatology Annual Meeting.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.